MGNX Dec 2024 17.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:46AM EDT. Market open.
| Previous close | 5.10 |
| Open | 5.50 |
| Bid | 0.00 |
| Ask | 1.05 |
| Strike | 17.50 |
| Expiry date | 2024-12-20 |
| Day's range | 5.10 - 5.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
GlobeNewswireMacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month: The Citizens JMP Life Sciences Conference (New York). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will parti
Simply Wall St.US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results
As you might know, MacroGenics, Inc. ( NASDAQ:MGNX ) last week released its latest first-quarter, and things did not...
- GuruFocus.com
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ...
Insight into Macrogenics' Financial Health and Future Clinical Prospects
© 2024 Yahoo. All rights reserved.